Navigation Links
NSF International Certifies Purity of Four Mannatech Products

NSF also certifies that Mannatech's manufacturer meets Good Manufacturing


COPPELL, Texas, June 25 /PRNewswire-FirstCall/ -- Mannatech, Incorporated (Nasdaq: MTEX), a leading developer and provider of dietary supplements and skin care solutions, today announced that the purity of Mannatech's Ambrotose and Advanced Ambrotose glyconutritional supplements has been certified by an independent, accredited testing laboratory. d=173

NSF International -- a not-for-profit public health certification organization -- ensures a product's label reflects the contents of the supplement, that all ingredients are openly disclosed on the label and that the product's purity is acceptable. Additionally, NSF assesses each manufacturing site to ensure it complies with Good Manufacturing Practices (GMP); NSF will not certify a product unless the manufacturer meets these rigorous audits.

NSF evaluated the capsule and powder versions of the Ambrotose and Advanced Ambrotose supplements. The products were certified according to the NSF/ANSI 173 Dietary Supplement Standard -- the only American National Standard for dietary supplements. Mannatech intends to carry the NSF certification mark on the supplements' labels and promotional materials to demonstrate compliance.

"NSF certification is just one part of the extraordinary quality and purity measures Mannatech adheres to throughout its product management process," said Marika Berkley, vice president of global regulatory affairs and quality assurance. "In addition to selecting ingredients that meet our rigorous purity standards, Mannatech ensures all its manufacturers adhere to industry-standard GMPs. We continually monitor our manufacturing partners and conduct frequent in-house and independent tests of the efficacy and purity of our products."

Edward Wyszumiala, general manager of NSF's dietary supplements programs, said, "Certification to the NSF/ANSI standard exemplifies Mannatech's emphasis on quality."

Mannatech began the NSF certification process with its flagship Ambrotose products -- the world's first glyconutritional dietary supplements. These dietary supplement products include a patented blend of plant-sourced saccharides. More than 43 patents worldwide have been issued for the technology related to the Ambrotose complex formulation. Mannatech is working with NSF to certify additional products in Mannatech's portfolio.

"Particularly on matters of health and wellness, quality is something that knowledgeable customers will never compromise," said Robert A. Sinnott, senior vice president of research and development. "Mannatech has built a loyal following of highly enlightened health advocates, particularly among the baby-boom generation. This third-party certification of Mannatech's flagship Ambrotose products confirms what Mannatech's customers have known for many years -- Mannatech is committed to pursuing the highest standards of product quality and product science."

About Mannatech

Mannatech, Incorporated, is a global wellness solutions provider of innovative, high-quality, proprietary nutritional supplements, topical and skin care products, and weight management products sold through independent associates and members located in the United States and the international markets of Canada, Australia, the United Kingdom, Japan, New Zealand, the Republic of Korea, Taiwan, Denmark, Germany, and South Africa.

About NSF International

NSF International, an independent, not-for-profit organization, helps protect you by certifying products and writing standards for food, water, air and consumer goods such as dietary supplements ( Founded in 1944, NSF is committed to protecting public health and safety worldwide. NSF is a World Health Organization Collaborating Centre for Food and Water Safety and Indoor Environment. Additional services include safety audits for the food and water industries, management systems registrations delivered through NSF International Strategic Registrations, Ltd., organic certification provided by Quality Assurance International and education through the NSF Center for Public Health Education.

Please Note: This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by use of phrases or terminology such as "intend" or other similar words or the negative of such terminology. Similarly, descriptions of Mannatech's objectives, strategies, plans, goals or targets contained herein are also considered forward-looking statements. Mannatech believes this release should be read in conjunction with all of its filings with the United States Securities and Exchange Commission and cautions its readers that these forward-looking statements are subject to certain events, risks, uncertainties, and other factors. Some of these factors include, among others, Mannatech's inability to attract and retain associates and members, increases in competition, litigation, regulatory changes, and its planned growth into new international markets. Although Mannatech believes that the expectations, statements, and assumptions reflected in these forward-looking statements are reasonable, it cautions readers to always consider all of the risk factors and any other cautionary statements carefully in evaluating each forward-looking statement in this release, as well as those set forth in its latest Annual Report on Form 10-K and Quarterly Report on Form 10-Q, and other filings filed with the United States Securities and Exchange Commission, including its current reports on Form 8-K. All of the forward-looking statements contained herein speak only as of the date of this release.

Mannatech Contact Information:

Gary Spinell, Vice President

Corporate Communications


Corporate website:

NSF Contact Information:

Ed Wyszumiala

NSF International


SOURCE Mannatech, Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. International study strengthens case for daily calcium pill
2. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
3. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
4. LCA Hails International Investigators Studying Lung Cancer
5. Arrow International Urges Shareholders To Vote for Approval of the $45.50 Teleflex Inc. Merger and for the Current Board of Directors
6. PRA International Adds Dr. Susan Stansfield as Executive Vice President
7. Medical Services International Maintains Pace in Second Quarter
8. Clarity Imaging International, Inc. Rolls Out Mobile DEXA Program
9. International Gateway Insurance Brokers Partners With MEDILINQ
10. Tulane University to receive $14M for international HIV/AIDS program
11. International Database Seeks to Boost Treatment of Altitude Sickness
Post Your Comments:
(Date:12/1/2015)... Fla. (PRWEB) , ... December 01, 2015 , ... ... number of leadless pacemakers in the U.S. and is the only hospital in ... from the largest clinical data presentation of transcatheter pacing patients were revealed recently ...
(Date:12/1/2015)... ... December 01, 2015 , ... Growth in medical payments per workers’ ... in utilization of hospital and nonhospital care, according to a recent study by the ... Louisiana, 16th Edition , found medical payments per claim with more than seven days ...
(Date:12/1/2015)... ... December 01, 2015 , ... It’s official: Tattoo taboo is ... a number even greater among Millennials (a whopping one in three aged 18 to ... people who are dissatisfied with their ink. In fact, RealSelf , the world’s ...
(Date:12/1/2015)... ... December 01, 2015 , ... For many X-rays taken at ... accurate interpretation by the radiologist. The marking utensils are so small, however, they ... found a way to alleviate this problem. , He developed the patent-pending MARK ...
(Date:12/1/2015)... , ... December 01, 2015 , ... ... it has been selected as a finalist in this year’s Fierce Innovation Awards: ... Next IT Healthcare was recognized as a finalist in the category of Digital ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... Pa. , Dec. 1, 2015  Today, ... announced the launch of CareFront, a first-of-its-kind population ... patients diagnosed with cancer. Designed to be built ... diagnosed cancer patients with resources for their care ... The program also offers tools to help patients ...
(Date:12/1/2015)... , Dec. 1, 2015   Craneware, ... value cycle solutions, today announced the company will ... Pharmacy ChargeLink ® solution at the ... Midyear Clinical Meeting . The new features are ... process of monitoring and managing enterprise-wide pharmacy charges ...
(Date:12/1/2015)... 1, 2015  Booth #3506 – Claymount is featuring its ... meeting of the Radiological Society of North America ... year. Based in the Netherlands , Claymount ... Systems (NYSE: VAR ) and is one of the ... solid state automatic exposure control systems for controlling dose during ...
Breaking Medicine Technology: